Articles with "model schizophrenia" as a keyword



Photo from wikipedia

The instrumental role of operant paradigms in translational psychiatric research: Insights from a maternal immune activation model of schizophrenia risk

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of the Experimental Analysis of Behavior"

DOI: 10.1002/jeab.753

Abstract: Rigorous behavioral analysis is essential to the translation of research conducted using animal models of neuropsychiatric disease. Here we discuss the use of operant paradigms within our lab as a powerful approach for exploring the… read more here.

Keywords: operant paradigms; model schizophrenia; maternal immune; research ... See more keywords
Photo from archive.org

Proteomic Profiling of Skin Fibroblasts as a Model of Schizophrenia.

Sign Up to like & get
recommendations!
Published in 2017 at "Advances in experimental medicine and biology"

DOI: 10.1007/978-3-319-52479-5_29

Abstract: Since many aspects of schizophrenia are also manifested at the peripheral level in proliferating cell types, this chapter describes the analysis of skin fibroblasts biopsied from living patients. The method focuses on cell culture and… read more here.

Keywords: fibroblasts model; skin; proteomic profiling; model schizophrenia ... See more keywords
Photo by thetonik_co from unsplash

1MeTIQ and olanzapine, despite their neurochemical impact, did not ameliorate performance in fear conditioning and social interaction tests in an MK-801 rat model of schizophrenia

Sign Up to like & get
recommendations!
Published in 2021 at "Pharmacological Reports"

DOI: 10.1007/s43440-020-00209-9

Abstract: Background The aim of the present study was to evaluate the effect of 1MeTIQ on fear memory and social interaction in an MK-801-induced model of schizophrenia. The results obtained after administration of 1MeTIQ were compared… read more here.

Keywords: 1metiq olanzapine; fear; 801 induced; model schizophrenia ... See more keywords
Photo by thinkmagically from unsplash

Adolescent environmental enrichment prevents the emergence of schizophrenia-like abnormalities in a neurodevelopmental model of schizophrenia

Sign Up to like & get
recommendations!
Published in 2018 at "European Neuropsychopharmacology"

DOI: 10.1016/j.euroneuro.2017.11.013

Abstract: In the present study, we investigated whether exposure to an enriched environment (EE) during adolescence might affect the behavioural dysfunction (sensorimotor gating deficit, memory and social interaction impairments) and neurochemical changes (GAD67 expression, histone methylation)… read more here.

Keywords: enrichment prevents; schizophrenia; model schizophrenia; environmental enrichment ... See more keywords
Photo from wikipedia

Increased thin-spine density in frontal cortex pyramidal neurons in a genetic rat model of schizophrenia-relevant features

Sign Up to like & get
recommendations!
Published in 2021 at "European Neuropsychopharmacology"

DOI: 10.1016/j.euroneuro.2021.01.006

Abstract: The cellular mechanisms altered during brain wiring leading to cognitive disturbances in neurodevelopmental disorders remain unknown. We have previously reported altered cortical expression of neurodevelopmentally regulated synaptic markers in a genetic animal model of schizophrenia-relevant… read more here.

Keywords: model schizophrenia; spine density; schizophrenia relevant; density ... See more keywords
Photo from wikipedia

Medial septum modulates hippocampal gamma activity and prepulse inhibition in an N-methyl-d-aspartate receptor antagonist model of schizophrenia

Sign Up to like & get
recommendations!
Published in 2018 at "Schizophrenia Research"

DOI: 10.1016/j.schres.2017.07.053

Abstract: We reviewed the participation of the septohippocampal system in an animal model of schizophrenia that was acutely induced by systemic injection of an N-methyl-d-aspartate (NMDA) receptor antagonist such as phencyclidine, MK-801 and ketamine. The NMDA… read more here.

Keywords: receptor antagonist; hippocampal gamma; model schizophrenia; receptor ... See more keywords
Photo by anotherlovely from unsplash

α7 Nicotinic receptor-modulating agents reverse the hyperdopaminergic tone in the MAM model of schizophrenia

Sign Up to like & get
recommendations!
Published in 2018 at "Neuropsychopharmacology"

DOI: 10.1038/s41386-018-0066-0

Abstract: Recent evidence has emerged supporting a role for the cholinergic system in schizophrenia, including the potential of α7 modulators as a treatment strategy. However, preclinical studies to date have relied on studies in normal systems… read more here.

Keywords: mam; hyperdopaminergic tone; tone mam; model schizophrenia ... See more keywords
Photo from wikipedia

Mesenchymal stem cells derived extracellular vesicles improve behavioral and biochemical deficits in a phencyclidine model of schizophrenia

Sign Up to like & get
recommendations!
Published in 2020 at "Translational Psychiatry"

DOI: 10.1038/s41398-020-00988-y

Abstract: Schizophrenia is a debilitating psychiatric disorder with a significant number of patients not adequately responding to treatment. Phencyclidine (PCP) is used as a validated model for schizophrenia, shown to reliably induce positive, negative and cognitive-like… read more here.

Keywords: schizophrenia; model schizophrenia; treated mice; stem cells ... See more keywords
Photo by _k_arinn from unsplash

Pitfalls of NMDA Receptor Modulation by Neuroactive Steroids. The Effect of Positive and Negative Modulation of NMDA Receptors in an Animal Model of Schizophrenia

Sign Up to like & get
recommendations!
Published in 2021 at "Biomolecules"

DOI: 10.3390/biom11071026

Abstract: Evidence from clinical and preclinical studies implicates dysfunction of N-methyl-D-aspartate receptors (NMDARs) in schizophrenia progression and symptoms. We investigated the antipsychotic effect of two neuroactive steroids in an animal model of schizophrenia induced by systemic… read more here.

Keywords: neuroactive steroids; modulation; animal model; nmda receptor ... See more keywords
Photo by thinkmagically from unsplash

N-Acetylcysteine and Aripiprazole Improve Social Behavior and Cognition and Modulate Brain BDNF Levels in a Rat Model of Schizophrenia

Sign Up to like & get
recommendations!
Published in 2022 at "International Journal of Molecular Sciences"

DOI: 10.3390/ijms23042125

Abstract: Treatment of negative symptoms and cognitive disorders in patients with schizophrenia is still a serious clinical problem. The aim of our study was to compare the efficacy of chronic administration of the atypical antipsychotic drug… read more here.

Keywords: bdnf levels; model schizophrenia; schizophrenia; brain ... See more keywords